Leadership at the Personalization Frontier: When the CMO Owns Inference Spend
Editorial hero: abstract systems graphic for leadership — Deep Navy (#1A2332) and Electric Blue (#0066FF). Wordless FinOps / assurance metaphor.

Editorial hero: abstract systems graphic for leadership — Deep Navy (#1A2332) and Electric Blue (#0066FF). Wordless FinOps / assurance metaphor.

Continue reading
Stay in the thread—related operator essays chosen for topic fit and format variety.

Healthcare bottlenecks are coordination, not diagnosis—clinical workflow operators screen populations, assemble context, route handoffs, and audit milestones while clinicians keep judgment.

Central AI pools hide run-rate creep—chargeback ties inference spend to decision volume and named P&L owners so product optimizes $/decision, not demos.

Five board metrics that survive audit—production workflows, $/decision, eval-to-incident correlation, tier-2 incidents, and shadow-tool exposure—with definitions finance and risk can reuse.
| Signal | Owner | Monthly volume | $/decision | Control status |
|---|---|---|---|---|
| Primary workflow | VP Operations | 28,400 | $0.09 | Tagged |
| Escalation path | Risk / Compliance | 1,120 | $1.42 | Tagged |
| Batch / embed jobs | Platform (shared) | n/a | n/a | Untagged |
Free preview
You are seeing a short preview of “Leadership at the Personalization Frontier: When the CMO Owns Inference Spend.” Sign in or create a free account to read the full essay, figures, and complete argument in the archive.